Centennial Bank
IBB icon

Centennial Bank’s iShares Biotechnology ETF IBB Stock Holding History

Centennial Bank’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$15.8K Hold
75
– – ﹤0.01% 275
2026
Q2 		$14.3K Hold
75
– – ﹤0.01% 282
2026
Q1 		$12.7K Hold
75
– – ﹤0.01% 269
2025
Q4 		$12.7K Hold
75
– – 0.01% 275
2025
Q3 		$10.8K Hold
75
– – ﹤0.01% 279
2025
Q2 		$9.49K Hold
75
– – ﹤0.01% 286
2025
Q1 		$9.6K Hold
75
– – ﹤0.01% 281
2024
Q4 		$9.9K Hold
75
– – ﹤0.01% 264
2024
Q3 		$10.9K Hold
75
– – 0.01% 267
2024
Q2 		$10.3K Sell
75
-2
-3% -$267 0.01% 267
2024
Q1 		$10.6K Hold
77
– – 0.01% 269
2023
Q4 		$10.5K Hold
77
– – 0.01% 268
2023
Q3 		$9.42K Hold
77
– – 0.01% 264
2023
Q2 		$9.8K Hold
77
– – 0.01% 267
2023
Q1 		$9.9K Hold
77
– – 0.01% 267
2022
Q4 		$10.1K Buy
+77
New +$10K 0.01% 281

Other funds holding IBB

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
WestEnd Advisors
WestEnd Advisors Charlotte, North Carolina $4.53B AUM 12.98% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $61B AUM 26.91% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $313B AUM 26.62% 1-Year Est. Return

Centennial Bank's IBB Position: Q3 2026 in Review

Centennial Bank held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 75 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Centennial Bank first reported a position in IBB in Q4 2022 and has held it in 16 quarters since. 700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.

  • Centennial Bank held 75 shares of iShares Biotechnology ETF worth $15.8K as of Q3 2026.
  • Centennial Bank left its iShares Biotechnology ETF share count unchanged in Q3 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Centennial Bank's portfolio in Q3 2026, its #275 holding.
  • Centennial Bank first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 16 quarters since.
  • 700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.

Based on Centennial Bank's 13F filing for Q3 2026, filed 9 Nov 2026.